Document complet  |  Dérouler chapitre  |  Etendre sommaire  |  Version HTML imprimable
Highlights of the Year 2000 in Essential Drugs and Medicines Policy
(2001; 12 pages) [French] [Spanish] Voir le document au format PDF
Table des matières
Afficher le documentPolicy: Vital for health systems development
Afficher le documentAccess: Framework for collective action
Afficher le documentQuality and safety: Information for action
Afficher le documentRational use: Action at all levels of care
Afficher le documentContacts
 

Highlights of the Year 2000 in Essential Drugs and Medicines Policy

WHO

Essential drugs save lives and improve health - but only if they are available, affordable, safe and properly used. In 2000 significant progress was made in: strengthening national pharmaceutical programmes, with notable achievements in countries in each of the six WHO regions; developing effective drug regulation; maximizing the impact of WHO clinical guidelines; helping countries respond to the impact of trade on their pharmaceutical sector; promoting safe and effective use of traditional medicine; and monitoring WHO’s work in essential drugs and medicines policy.

WHO’s current priority in medicines is to expand access to essential drugs, particularly for low-income and disadvantaged populations. Considerable progress is being made on drug selection and drug pricing. In 2001, greater focus is being put on financing, supply systems and quality assurance - areas in which effective work with countries and partner-ships with other international organizations, aid agencies and nongovernmental organizations are crucial for achieving sound, sustainable results.

Dr Yasuhiro Suzuki, Executive Director
Health Technology and Pharmaceuticals
and
Dr Jonathan Quick, Director
Department of Essential Drugs and Medicines Policy


Figure 1: The WHO Medicines Strategy 2000-2003 - the pharmaceutical foundation for improved health outcomes and stronger health systems

 

vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 7 octobre 2014